Skip to main content

Neoadjuvant XL092 + Cemiplimab

XL092 and Cemiplimab in BRAF WT Thyroid Cancer

  • RegistryNCT06902376
  • PhasePhase 1
  • StatusRecruiting
  • ConditionBRAF V600E Wild-Type Anaplastic Thyroid Cancer
  • SponsorUNC Lineberger Comprehensive Cancer Center
How NEO-COMBATXL worksNCT069023761 min

What the film says

Read the transcript

This trial is for adults with anaplastic thyroid cancer that does not carry the BRAF V600E mutation and who are scheduled for surgery.

The idea: before surgery, combine XL092, a daily pill, with the immunotherapy cemiplimab, given by vein every three weeks for three doses. XL092 is taken for eight weeks.

This phase 1 study plans 12 patients and looks at safety and whether the tumor can be completely removed. At UNC Lineberger Comprehensive Cancer Center in Chapel Hill, Siddharth Sheth leads it.

Public record; not medical advice.

Sources behind this film

  • ClinicalTrials.gov record NCT06902376

    Adults; BRAF V600E wild type anaplastic thyroid cancer, scheduled for surgery; Neoadjuvant XL092 daily pill plus cemiplimab IV every 3 weeks, 3 doses; XL092 eight weeks; Phase 1; 12 patients; safety and complete resection; UNC Lineberger, Chapel Hill; Siddharth Sheth

The drug

What is being tested.

XL092 will be administered at a dose of 60mg PO daily for 8 weeks (weeks 1-8)

Cemiplimab will be administered at a dose of 350mg intravenous over 30 minutes every 3 weeks for 3 cycles (cycle length is 21 days) at weeks 1, 4, and 7.

This study includes subjects with BRAFV600E wild type (WT) anaplastic thyroid cancer (ATC) who are scheduled to undergo surgical resection as part of their standard of care. The study hypothesizes that the combination of neoadjuvant XL092 and cemiplimab will be safe and feasible prior to surgical resection in participants with BRAF V600E-WT ATC. Anaplastic thyroid cancer (ATC) is a highly aggressive and fatal malignancy.

The study

How the trial runs.

This multicenter study examines the safety and feasibility of the combination of neoadjuvant XL092 and cemiplimab prior to surgical resection in participants with wild-type (WT) anaplastic thyroid cancer (ATC) that has a BRAF mutation (BRAF V600E).

Live record on ClinicalTrials.gov →

Eligibility

Who the study is looking for.

  • Written informed consent was obtained to participate in the study and HIPAA authorization for the release of personal health information.
  • Subjects are willing and able to comply with study procedures based on the judgment of the investigator.
  • Age ≥ 18 years at the time of consent.
  • the Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2.
  • Pathologic findings supporting the clinical impression of anaplastic thyroid cancer. Terminology consistent or suggestive of diagnosis may include the following: anaplastic thyroid carcinoma, undifferentiated carcinoma, squamous carcinoma; carcinoma with spindled, giant cell, or epithelial features; poorly differentiated carcinoma with pleomorphism, extensive necrosis with tumor cells present.
  • Subject is willing to have a fresh biopsy at least 3 days prior to neoadjuvant therapy if archival tissue is unavailable. Also willing to have a biopsy at the time of SOC surgery, if applicable.

Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.

For you, or someone you love

Whether or not this trial is the one, bring AI into your corner.

A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.

Start your 7-day free trial

Then $9 a month. Cancel anytime.

  • Every record in one place

    Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.

  • Read in plain words

    Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.

  • Ready for every appointment

    Ask about your own file, and walk in with questions for your oncologist or the trial team.

  • Your people, in the loop

    Share one profile with the family helping you, and with your doctors.

Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.

How these trials work: what Phase 1 actually is · common questions Not clinical evidence.